Cytespace Africa Laboratories Expands to Drive Cost-Efficient Clinical Trials Across Sub-Saharan Africa

New infrastructure strengthens Africa-based clinical trial logistics, reducing costs and accelerating timelines for global sponsors across Sub-Saharan Africa

CITY OF TSHWANE, GAUTENG, SOUTH AFRICA, March 4, 2026 /EINPresswire.com/ -- Cytespace Africa Laboratories (“Cytespace”), an MLM Company, today announced a major expansion of its infrastructure and specialist capacity to support the accelerating growth of clinical trial activity across Sub-Saharan Africa.

As global sponsors increasingly expand clinical development into Sub-Saharan Africa, recognizing both the region’s growing research capacity and its important role in addressing global health priorities, the need for strong, locally anchored laboratory and logistics infrastructure has become critical. Cytespace provides fully integrated, in-region kit building, specimen management, biorepository storage, and laboratory testing, reducing reliance on international freight while maintaining globally harmonized quality standards.

“The future of clinical research in Africa depends on building strong, local infrastructure,” said Scott Houlton, CEO of MLM Medical Labs (“MLM”). “By enabling kit building, specimen management, and testing within South Africa and across the continent, we reduce logistics complexity, control costs, and accelerate study timelines - while maintaining the highest global quality standards. Investing locally is essential for delivering sustainable, scalable clinical trials in Africa.”

Market Momentum
The African clinical trials market is projected to reach USD $1.68 billion by 2032, growing at an estimated 7.2% compound annual growth rate, with South Africa positioned as a leading regional research hub.

Since 1999, Cytespace has supported more than 1,200 clinical studies across South Africa and Sub-Saharan Africa, demonstrating its operational expertise in managing complex, multi-site clinical programs in the region.

Expanded Kit Building and Specimen Management Capacity
To meet rising demand, Cytespace has expanded and relocated its Kit Building Department into a larger, purpose-designed facility that increases throughput and enhances workflow efficiency.

The upgraded infrastructure supports:
• Higher kit assembly volumes for regional and multinational trials
• Faster study start-up and deployment
• Optimized process flow efficiency to support complex, multi-site protocols
• Reduced turnaround times

In parallel, Cytespace has strengthened its Specimen Management and biorepository capabilities with expanded controlled storage and ultra-low-temperature freezer capacity. The enhanced platform increases specimen intake, supports long-term preservation, and reinforces chain-of-custody traceability aligned with international quality standards.

Measurable Sponsor Advantages
Localizing kit building, specimen management, and laboratory operations within Sub-Saharan Africa delivers clear operational and economic benefits for sponsors:
• Reduced international freight and cold-chain transport costs
• Fewer customs delays and cross-border regulatory barriers
• Faster kit deployment and sample processing
• Greater resilience for multi-country African studies
• Improved timeline predictability

As an MLM Company, Cytespace operates within globally aligned quality standards while delivering regionally responsive execution.

________________________________________

About MLM Medical Labs | www.mlm-labs.com
MLM Medical Labs is an international central and specialty laboratory with harmonized operations in Europe, North America, and South Africa. With over 30 years of experience, MLM supports more than 300 clinical trials at any given time, offering services including central lab testing, biomarker discovery, kit building, assay development, and long-term sample storage. MLM is known for scientific expertise, rapid startup, flexible logistics, and full regulatory compliance.

About Cytespace Africa Laboratories | www.cytespacelabs.com
Cytespace Africa Laboratories, an MLM Medical Labs company, is the only fully CAP-accredited central laboratory in South Africa. Established in 1999, it offers full-service central lab capabilities under one roof, including project management, molecular diagnostics, safety testing, kit building, and sample logistics. With over 1,200 trials supported, the lab is a trusted partner for global Sponsors operating in Africa.

________________________________________

Media Contacts:
Annette Angenendt
MLM Medical Labs
Email: AAngenendt@mlm-labs.com

Susan Massyn
Executive Support Manager
Cytespace Africa Laboratories
Email: susan.massyn@cytespacelabs.com

Susan Massyn
Cytespace Africa Laboratories
susan.massyn@cytespacelabs.com
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.